FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, Dec 17, 2008
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on December 17, 2008, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma Plasma, Inc.
- Inspection Date
- December 17, 2008
- Product Type
- Biologics
View Company Profile
ID · bd367218-6a8a-4573-b6b3-957783b454ce
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 552992
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 640.72(a)(4)Certification of donor"s health
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 12, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 31, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 26, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 1102778 - 2019-08-12
- FDA Inspection 988583 - 2016-08-31
- FDA Inspection 841994 - 2013-07-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.